Login / Signup

Nogo-A regulates myogenesis via interacting with Filamin-C.

SunYoung ParkJi-Hwan ParkUn-Beom KangSeong-Kyoon ChoiAhmed ElfadlH M Arif UllahMyung-Jin ChungJi-Yoon SonHyun Ho YunJae-Min ParkJae-Hyuk YimSeung-Jun JungSang-Hyup KimYoung-Chul ChoiDae-Seong KimJin-Hong ShinJin-Sung ParkKeun HurSang-Han LeeEun-Joo LeeDaehee HwangKyu-Shik Jeong
Published in: Cell death discovery (2021)
Among the three isoforms encoded by Rtn4, Nogo-A has been intensely investigated as a central nervous system inhibitor. Although Nogo-A expression is increased in muscles of patients with amyotrophic lateral sclerosis, its role in muscle homeostasis and regeneration is not well elucidated. In this study, we discovered a significant increase in Nogo-A expression in various muscle-related pathological conditions. Nogo-/- mice displayed dystrophic muscle structure, dysregulated muscle regeneration following injury, and altered gene expression involving lipid storage and muscle cell differentiation. We hypothesized that increased Nogo-A levels might regulate muscle regeneration. Differentiating myoblasts exhibited Nogo-A upregulation and silencing Nogo-A abrogated myoblast differentiation. Nogo-A interacted with filamin-C, suggesting a role for Nogo-A in cytoskeletal arrangement during myogenesis. In conclusion, Nogo-A maintains muscle homeostasis and integrity, and pathologically altered Nogo-A expression mediates muscle regeneration, suggesting Nogo-A as a novel target for the treatment of myopathies in clinical settings.
Keyphrases